Charles Schwab Investment Management Inc. Buys 212,161 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Charles Schwab Investment Management Inc. boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 3.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,905,998 shares of the pharmacy operator’s stock after buying an additional 212,161 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.68% of Walgreens Boots Alliance worth $131,349,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of WBA. Vontobel Holding Ltd. raised its position in Walgreens Boots Alliance by 104.6% in the 1st quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock worth $1,752,000 after buying an additional 18,879 shares during the last quarter. Moors & Cabot Inc. raised its position in Walgreens Boots Alliance by 31.1% in the 1st quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock worth $931,000 after buying an additional 4,931 shares during the last quarter. Sequoia Financial Advisors LLC raised its position in Walgreens Boots Alliance by 27.9% in the 1st quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock worth $339,000 after buying an additional 1,651 shares during the last quarter. Candriam Luxembourg S.C.A. raised its position in Walgreens Boots Alliance by 0.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after buying an additional 310 shares during the last quarter. Finally, Baird Financial Group Inc. raised its position in Walgreens Boots Alliance by 14.2% in the 1st quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock worth $20,932,000 after buying an additional 58,184 shares during the last quarter. Hedge funds and other institutional investors own 57.92% of the company’s stock.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The shares were acquired at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the purchase, the director now directly owns 4,456 shares in the company, valued at approximately $99,992.64. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Valerie B. Jarrett purchased 4,456 shares of the company’s stock in a transaction dated Monday, January 29th. The shares were acquired at an average price of $22.44 per share, with a total value of $99,992.64. Following the transaction, the director now owns 4,456 shares of the company’s stock, valued at $99,992.64. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Nancy M. Schlichting sold 15,209 shares of the stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $23.05, for a total value of $350,567.45. The disclosure for this sale can be found here. Insiders own 17.40% of the company’s stock.

Wall Street Analysts Forecast Growth

WBA has been the subject of several research reports. Barclays initiated coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target for the company. Royal Bank of Canada reduced their price target on shares of Walgreens Boots Alliance from $29.00 to $26.00 and set a “sector perform” rating for the company in a research report on Friday, October 13th. HSBC initiated coverage on shares of Walgreens Boots Alliance in a research report on Friday, December 22nd. They set a “hold” rating and a $27.00 price target for the company. JPMorgan Chase & Co. raised shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and upped their price target for the company from $27.00 to $30.00 in a research report on Monday, October 23rd. Finally, TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $28.25.

Get Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Trading Down 1.3 %

Shares of NASDAQ:WBA opened at $22.24 on Friday. The stock has a 50 day moving average of $23.88 and a 200 day moving average of $23.69. The company has a market cap of $19.18 billion, a PE ratio of 33.70, a price-to-earnings-growth ratio of 1.39 and a beta of 0.74. The company has a current ratio of 0.66, a quick ratio of 0.30 and a debt-to-equity ratio of 0.27. Walgreens Boots Alliance, Inc. has a 12-month low of $19.68 and a 12-month high of $37.13.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.04. Walgreens Boots Alliance had a return on equity of 10.48% and a net margin of 0.40%. The business had revenue of $36.70 billion during the quarter, compared to the consensus estimate of $34.95 billion. During the same period in the prior year, the company posted $1.16 EPS. The firm’s revenue for the quarter was up 9.9% compared to the same quarter last year. As a group, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 3.25 EPS for the current year.

Walgreens Boots Alliance Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 12th. Shareholders of record on Tuesday, February 20th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Friday, February 16th. This represents a $1.00 dividend on an annualized basis and a yield of 4.50%. Walgreens Boots Alliance’s payout ratio is 290.91%.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.